Author

Michael E. Hurwitz

Yale Cancer CenterORCID 0000-0002-1326-7308Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1

Frequent Co-Authors

Andrew J. DanielsiD· 1 shared Danielle K. SohaiiD· 1 shared Goran MiceviciD· 1 shared Henna S. Nam· 1 shared Kamal ObbadiD· 1 shared Karen S. AndersoniD· 1 shared Koonam ParkiD· 1 shared Krasimir A. SpasoviD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrew J. DanielsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintJul 6, 2026

Targeting DNMT1 augments anti-tumor CD8⁺ T cell function

Maya G. Deshmukh, Danielle K. Sohai, Kamal Obbad…·Goran Micevic

This study shows that inhibiting DNMT1 improves CD8+ T cell function in the tumor microenvironment and enhances the effectiveness of immune checkpoint inhibitors in a melanoma model.

DOI 10.64898/2026.07.03.736412

mousebulk RNA-seq

𝕏 PostBluesky